TQVAX | VIVIX | TQVAX / VIVIX | |
Total Expense Ratio | 0.99 | 0.04 | 2,475% |
Annual Report Gross Expense Ratio | 2.33 | 0.04 | 5,825% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | -0.346 | -0.669 | 52% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 65.5M | 184B | 0% |
Annual Yield % from dividends | 1.14 | 2.35 | 48% |
Returns for 1 year | -1.47 | 4.59 | -32% |
Returns for 3 years | 10.20 | 21.42 | 48% |
Returns for 5 years | 67.82 | 72.66 | 93% |
Returns for 10 years | N/A | 97.34 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRKTX | 14.55 | 0.06 | +0.41% |
MFS Blended Research Em Mkts Eq R3 | |||
SCWFX | 65.10 | 0.21 | +0.32% |
American Funds SMALLCAP World F1 | |||
BOSVX | 16.12 | 0.05 | +0.31% |
Bridgeway Omni Small-Cap Value N | |||
CTCAX | 80.48 | -0.06 | -0.07% |
Columbia Global Technology Growth A | |||
ASIMX | 12.73 | -0.15 | -1.16% |
Alger Weatherbie Specialized Growth I |